News Focus
News Focus
icon url

$heff

04/25/10 11:52 PM

#26961 RE: jas2mel #26954

POZN ($10.86)…Vimovo is a featured product for Astra Zeneca in their 2009 Shareholder Meeting. POZN is not alone in wanting this product to be approved! A lot on the line here and POZN has a key partner in the U.S. and internationally.